ExodusPoint Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$81K Buy
2021
Q3
Sell
2021
Q2
$135K Buy
2019
Q2
Sell
2019
Q1
$362K Buy
2018
Q4
$119K Buy